Josef Brueggen Selected Research

Josef Brueggen Research Topics

Disease

8	Neoplasms (Cancer) 01/2011 - 07/2004
4	Melanoma (Melanoma, Malignant) 01/2011 - 08/2005
2	Breast Neoplasms (Breast Cancer) 04/2010 - 01/2008
2	Neoplasm Metastasis (Metastasis) 06/2006 - 08/2005
1	Hyperglycemia 01/2012
1	Polycythemia (Erythrocytosis) 07/2010
1	Carcinogenesis 01/2008
1	Colorectal Neoplasms (Colorectal Cancer) 06/2006
1	Neuroblastoma 10/2005
1	Glioma (Gliomas) 07/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2004

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 07/2010 - 10/2005
2	Proteins (Proteins, Gene)FDA Link 04/2010 - 01/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2006 - 08/2005
2	Tyrosine Kinase InhibitorsIBA 06/2006 - 08/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2006 - 08/2005
2	vatalanib (PTK787)IBA 06/2006 - 08/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2005 - 07/2004
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2012
1	somatostatin receptor 2IBA 01/2012
1	pasireotideIBA 01/2012
1	Glucagon (Glukagon)FDA Link 01/2012
1	Insulin (Novolin)FDA Link 01/2012
1	Everolimus FDA Link 01/2011
1	NVP-BSK805IBA 07/2010
1	QuinoxalinesIBA 07/2010
1	Erythropoietin FDA Link 07/2010
1	Valine (L-Valine)FDA Link 07/2010
1	Phenylalanine (L-Phenylalanine)FDA Link 07/2010
1	Amino Acids FDA Link 07/2010
1	NVP-BEP800IBA 04/2010
1	TOR Serine-Threonine KinasesIBA 07/2008
1	dactolisibIBA 07/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2008
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2008
1	Pharmaceutical PreparationsIBA 01/2008
1	Biomarkers (Surrogate Marker)IBA 06/2006
1	Biological ProductsIBA 06/2006
1	Imatinib Mesylate (Gleevec)FDA Link 10/2005
1	tyrosine receptor (receptor, tyrosine)IBA 10/2005
1	Tyrosine (L-Tyrosine)FDA Link 10/2005
1	ferumoxides (Feridex)FDA Link 08/2005
1	Contrast MediaIBA 08/2005
1	gadoterate meglumineIBA 08/2005
1	AEE 788 (AEE788)IBA 07/2004
1	ErbB Receptors (EGF Receptor)IBA 07/2004
1	Antineoplastic Agents (Antineoplastics)IBA 07/2004

Therapy/Procedure

2	Oral Administration 04/2010 - 07/2004
1	Therapeutics 08/2005